Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Sandborn WJ, D'Haens GR, Reinisch W, Panes J, et al. Gastroenterology 2022;162:1650-1664.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sandborn WJ, D'Haens GR, Reinisch W, Panes J, et al. Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology 2022;162:1650-1664.
PMID: 35134323